Cancer Survivors
Cross-source consensus on Cancer Survivors from 1 sources and 6 claims.
1 sources · 6 claims
Benefits
Risks & contraindications
Comparisons
Background
Where it comes from
Highlighted claims
- Japan's National Cancer Center estimated nearly one million new cancer cases and over 384,000 cancer deaths in 2021. — Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE study, Japan
- The final analytic cohort comprised 39,435 cancer survivors drawn from 13 Japanese municipalities. — Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE study, Japan
- The population of cancer survivors in developed countries is growing due to ageing, earlier detection, and improved treatment. — Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE study, Japan
- Cancer survivors may experience physical impairment, fatigue, and pain as consequences of cancer or its treatment. — Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE study, Japan
- Physical activity is recommended for cancer survivors to preserve activities of daily living, quality of life, and survival. — Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE study, Japan
- In breast cancer, a dose-response relationship between physical activity and five-year all-cause mortality was reported, with mortality dropping from 11% with no exercise to about 3% with 150 or more minutes per week. — Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE study, Japan